On Tuesday, pharmaceutical giant Johnson & Johnson released adjusted financials revealing that the company topped analysts’ earnings and revenue expectations during its third financial quarter.
Johnson & Johnson reportedly pulled in $2.66 in adjusted earnings per share compared to the $2.52 per share expected by Wall Street.
Likewise, the company brought in $21.35 billion in revenue versus analysts’ $21.04 billion prediction.
Johnson & Johnson went on to raise its full-year guidance as a result of its successful Q3.
